世界の症候群複合診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Syndromic Multiplex Diagnostic Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4923
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、117ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、症候群複合診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（消化器症候群多重診断、中枢神経系症候群多重診断、その他）、用途別市場規模（病院、診断研究所、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・症候群複合診断の市場動向
・企業の競争状況、市場シェア
・症候群複合診断の種類別市場規模と予測2016-2027（消化器症候群多重診断、中枢神経系症候群多重診断、その他）
・症候群複合診断の用途別市場規模と予測2016-2027（病院、診断研究所、研究所、その他）
・症候群複合診断の北米市場規模2016-2027（アメリカ、カナダ）
・症候群複合診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・症候群複合診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・症候群複合診断の中南米市場規模2016-2027（メキシコ、ブラジル）
・症候群複合診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abbott、Hologic、Bosch、Danaher、Johnson & Johnson、Danaher、Bio-Rad Laboratories、Luminex、bioMérieux、Qiagen、Alveo Technologies、Mesa Biotech、Applied BioCode、Akonni Biosystems、Diagenode Diagnostics）
・結論

Most patients with infectious illness have certain symptoms and signs that are indicative of a disease but becomes difficult to identify the actual causing agent. These set of signs and symptoms are referred to as syndrome.

Market Analysis and Insights: Global Syndromic Multiplex Diagnostic Market
The global Syndromic Multiplex Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Syndromic Multiplex Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Syndromic Multiplex Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Syndromic Multiplex Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Syndromic Multiplex Diagnostic market.

Global Syndromic Multiplex Diagnostic Scope and Market Size
Syndromic Multiplex Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Syndromic Multiplex Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Gastrointestinal Syndromic Multiplex Diagnostic
Central Nervous System Syndromic Multiplex Diagnostic
Others

Segment by Application
Hospitals
Diagnostics Laboratories
Research Institutes
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Hologic
Bosch
Danaher
Johnson & Johnson
Danaher
Bio-Rad Laboratories
Luminex
bioMérieux
Qiagen
Alveo Technologies
Mesa Biotech
Applied BioCode
Akonni Biosystems
Diagenode Diagnostics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Syndromic Multiplex Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gastrointestinal Syndromic Multiplex Diagnostic
1.2.3 Central Nervous System Syndromic Multiplex Diagnostic
1.2.4 Others
1.3 Market by Application
1.3.1 Global Syndromic Multiplex Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Diagnostics Laboratories
1.3.4 Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Syndromic Multiplex Diagnostic Market Perspective (2016-2027)
2.2 Syndromic Multiplex Diagnostic Growth Trends by Regions
2.2.1 Syndromic Multiplex Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Syndromic Multiplex Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Syndromic Multiplex Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Syndromic Multiplex Diagnostic Industry Dynamic
2.3.1 Syndromic Multiplex Diagnostic Market Trends
2.3.2 Syndromic Multiplex Diagnostic Market Drivers
2.3.3 Syndromic Multiplex Diagnostic Market Challenges
2.3.4 Syndromic Multiplex Diagnostic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Syndromic Multiplex Diagnostic Players by Revenue
3.1.1 Global Top Syndromic Multiplex Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Syndromic Multiplex Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Syndromic Multiplex Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Syndromic Multiplex Diagnostic Revenue
3.4 Global Syndromic Multiplex Diagnostic Market Concentration Ratio
3.4.1 Global Syndromic Multiplex Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Syndromic Multiplex Diagnostic Revenue in 2020
3.5 Syndromic Multiplex Diagnostic Key Players Head office and Area Served
3.6 Key Players Syndromic Multiplex Diagnostic Product Solution and Service
3.7 Date of Enter into Syndromic Multiplex Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Syndromic Multiplex Diagnostic Breakdown Data by Type
4.1 Global Syndromic Multiplex Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Syndromic Multiplex Diagnostic Forecasted Market Size by Type (2022-2027)

5 Syndromic Multiplex Diagnostic Breakdown Data by Application
5.1 Global Syndromic Multiplex Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Syndromic Multiplex Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Syndromic Multiplex Diagnostic Market Size (2016-2027)
6.2 North America Syndromic Multiplex Diagnostic Market Size by Type
6.2.1 North America Syndromic Multiplex Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Syndromic Multiplex Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Syndromic Multiplex Diagnostic Market Size by Type (2016-2027)
6.3 North America Syndromic Multiplex Diagnostic Market Size by Application
6.3.1 North America Syndromic Multiplex Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Syndromic Multiplex Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Syndromic Multiplex Diagnostic Market Size by Application (2016-2027)
6.4 North America Syndromic Multiplex Diagnostic Market Size by Country
6.4.1 North America Syndromic Multiplex Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Syndromic Multiplex Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Syndromic Multiplex Diagnostic Market Size (2016-2027)
7.2 Europe Syndromic Multiplex Diagnostic Market Size by Type
7.2.1 Europe Syndromic Multiplex Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Syndromic Multiplex Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Syndromic Multiplex Diagnostic Market Size by Type (2016-2027)
7.3 Europe Syndromic Multiplex Diagnostic Market Size by Application
7.3.1 Europe Syndromic Multiplex Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Syndromic Multiplex Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Syndromic Multiplex Diagnostic Market Size by Application (2016-2027)
7.4 Europe Syndromic Multiplex Diagnostic Market Size by Country
7.4.1 Europe Syndromic Multiplex Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Syndromic Multiplex Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Syndromic Multiplex Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Type
8.2.1 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Application
8.3.1 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Region
8.4.1 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Syndromic Multiplex Diagnostic Market Size (2016-2027)
9.2 Latin America Syndromic Multiplex Diagnostic Market Size by Type
9.2.1 Latin America Syndromic Multiplex Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Syndromic Multiplex Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Syndromic Multiplex Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Syndromic Multiplex Diagnostic Market Size by Application
9.3.1 Latin America Syndromic Multiplex Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Syndromic Multiplex Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Syndromic Multiplex Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Syndromic Multiplex Diagnostic Market Size by Country
9.4.1 Latin America Syndromic Multiplex Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Syndromic Multiplex Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Syndromic Multiplex Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Type
10.2.1 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Application
10.3.1 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Country
10.4.1 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Syndromic Multiplex Diagnostic Introduction
11.1.4 Abbott Revenue in Syndromic Multiplex Diagnostic Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Hologic
11.2.1 Hologic Company Details
11.2.2 Hologic Business Overview
11.2.3 Hologic Syndromic Multiplex Diagnostic Introduction
11.2.4 Hologic Revenue in Syndromic Multiplex Diagnostic Business (2016-2021)
11.2.5 Hologic Recent Development
11.3 Bosch
11.3.1 Bosch Company Details
11.3.2 Bosch Business Overview
11.3.3 Bosch Syndromic Multiplex Diagnostic Introduction
11.3.4 Bosch Revenue in Syndromic Multiplex Diagnostic Business (2016-2021)
11.3.5 Bosch Recent Development
11.4 Danaher
11.4.1 Danaher Company Details
11.4.2 Danaher Business Overview
11.4.3 Danaher Syndromic Multiplex Diagnostic Introduction
11.4.4 Danaher Revenue in Syndromic Multiplex Diagnostic Business (2016-2021)
11.4.5 Danaher Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Syndromic Multiplex Diagnostic Introduction
11.5.4 Johnson & Johnson Revenue in Syndromic Multiplex Diagnostic Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Danaher
11.6.1 Danaher Company Details
11.6.2 Danaher Business Overview
11.6.3 Danaher Syndromic Multiplex Diagnostic Introduction
11.6.4 Danaher Revenue in Syndromic Multiplex Diagnostic Business (2016-2021)
11.6.5 Danaher Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Syndromic Multiplex Diagnostic Introduction
11.7.4 Bio-Rad Laboratories Revenue in Syndromic Multiplex Diagnostic Business (2016-2021)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Luminex
11.8.1 Luminex Company Details
11.8.2 Luminex Business Overview
11.8.3 Luminex Syndromic Multiplex Diagnostic Introduction
11.8.4 Luminex Revenue in Syndromic Multiplex Diagnostic Business (2016-2021)
11.8.5 Luminex Recent Development
11.9 bioMérieux
11.9.1 bioMérieux Company Details
11.9.2 bioMérieux Business Overview
11.9.3 bioMérieux Syndromic Multiplex Diagnostic Introduction
11.9.4 bioMérieux Revenue in Syndromic Multiplex Diagnostic Business (2016-2021)
11.9.5 bioMérieux Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Syndromic Multiplex Diagnostic Introduction
11.10.4 Qiagen Revenue in Syndromic Multiplex Diagnostic Business (2016-2021)
11.10.5 Qiagen Recent Development
11.11 Alveo Technologies
11.11.1 Alveo Technologies Company Details
11.11.2 Alveo Technologies Business Overview
11.11.3 Alveo Technologies Syndromic Multiplex Diagnostic Introduction
11.11.4 Alveo Technologies Revenue in Syndromic Multiplex Diagnostic Business (2016-2021)
11.11.5 Alveo Technologies Recent Development
11.12 Mesa Biotech
11.12.1 Mesa Biotech Company Details
11.12.2 Mesa Biotech Business Overview
11.12.3 Mesa Biotech Syndromic Multiplex Diagnostic Introduction
11.12.4 Mesa Biotech Revenue in Syndromic Multiplex Diagnostic Business (2016-2021)
11.12.5 Mesa Biotech Recent Development
11.13 Applied BioCode
11.13.1 Applied BioCode Company Details
11.13.2 Applied BioCode Business Overview
11.13.3 Applied BioCode Syndromic Multiplex Diagnostic Introduction
11.13.4 Applied BioCode Revenue in Syndromic Multiplex Diagnostic Business (2016-2021)
11.13.5 Applied BioCode Recent Development
11.14 Akonni Biosystems
11.14.1 Akonni Biosystems Company Details
11.14.2 Akonni Biosystems Business Overview
11.14.3 Akonni Biosystems Syndromic Multiplex Diagnostic Introduction
11.14.4 Akonni Biosystems Revenue in Syndromic Multiplex Diagnostic Business (2016-2021)
11.14.5 Akonni Biosystems Recent Development
11.15 Diagenode Diagnostics
11.15.1 Diagenode Diagnostics Company Details
11.15.2 Diagenode Diagnostics Business Overview
11.15.3 Diagenode Diagnostics Syndromic Multiplex Diagnostic Introduction
11.15.4 Diagenode Diagnostics Revenue in Syndromic Multiplex Diagnostic Business (2016-2021)
11.15.5 Diagenode Diagnostics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Syndromic Multiplex Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gastrointestinal Syndromic Multiplex Diagnostic
Table 3. Key Players of Central Nervous System Syndromic Multiplex Diagnostic
Table 4. Key Players of Others
Table 5. Global Syndromic Multiplex Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Syndromic Multiplex Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Syndromic Multiplex Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Syndromic Multiplex Diagnostic Market Share by Regions (2016-2021)
Table 9. Global Syndromic Multiplex Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Syndromic Multiplex Diagnostic Market Share by Regions (2022-2027)
Table 11. Syndromic Multiplex Diagnostic Market Trends
Table 12. Syndromic Multiplex Diagnostic Market Drivers
Table 13. Syndromic Multiplex Diagnostic Market Challenges
Table 14. Syndromic Multiplex Diagnostic Market Restraints
Table 15. Global Syndromic Multiplex Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Syndromic Multiplex Diagnostic Market Share by Players (2016-2021)
Table 17. Global Top Syndromic Multiplex Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Syndromic Multiplex Diagnostic as of 2020)
Table 18. Ranking of Global Top Syndromic Multiplex Diagnostic Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Syndromic Multiplex Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Syndromic Multiplex Diagnostic Product Solution and Service
Table 22. Date of Enter into Syndromic Multiplex Diagnostic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Syndromic Multiplex Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Syndromic Multiplex Diagnostic Revenue Market Share by Type (2016-2021)
Table 26. Global Syndromic Multiplex Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Syndromic Multiplex Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Syndromic Multiplex Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Syndromic Multiplex Diagnostic Revenue Market Share by Application (2016-2021)
Table 30. Global Syndromic Multiplex Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Syndromic Multiplex Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Syndromic Multiplex Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Syndromic Multiplex Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Syndromic Multiplex Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Syndromic Multiplex Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Syndromic Multiplex Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Syndromic Multiplex Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Syndromic Multiplex Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Syndromic Multiplex Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Syndromic Multiplex Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Syndromic Multiplex Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Syndromic Multiplex Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Syndromic Multiplex Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Syndromic Multiplex Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Syndromic Multiplex Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Syndromic Multiplex Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Syndromic Multiplex Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Syndromic Multiplex Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Syndromic Multiplex Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Syndromic Multiplex Diagnostic Product
Table 65. Abbott Revenue in Syndromic Multiplex Diagnostic Business (2016-2021) & (US$ Million)
Table 66. Abbott Recent Development
Table 67. Hologic Company Details
Table 68. Hologic Business Overview
Table 69. Hologic Syndromic Multiplex Diagnostic Product
Table 70. Hologic Revenue in Syndromic Multiplex Diagnostic Business (2016-2021) & (US$ Million)
Table 71. Hologic Recent Development
Table 72. Bosch Company Details
Table 73. Bosch Business Overview
Table 74. Bosch Syndromic Multiplex Diagnostic Product
Table 75. Bosch Revenue in Syndromic Multiplex Diagnostic Business (2016-2021) & (US$ Million)
Table 76. Bosch Recent Development
Table 77. Danaher Company Details
Table 78. Danaher Business Overview
Table 79. Danaher Syndromic Multiplex Diagnostic Product
Table 80. Danaher Revenue in Syndromic Multiplex Diagnostic Business (2016-2021) & (US$ Million)
Table 81. Danaher Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Syndromic Multiplex Diagnostic Product
Table 85. Johnson & Johnson Revenue in Syndromic Multiplex Diagnostic Business (2016-2021) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. Danaher Company Details
Table 88. Danaher Business Overview
Table 89. Danaher Syndromic Multiplex Diagnostic Product
Table 90. Danaher Revenue in Syndromic Multiplex Diagnostic Business (2016-2021) & (US$ Million)
Table 91. Danaher Recent Development
Table 92. Bio-Rad Laboratories Company Details
Table 93. Bio-Rad Laboratories Business Overview
Table 94. Bio-Rad Laboratories Syndromic Multiplex Diagnostic Product
Table 95. Bio-Rad Laboratories Revenue in Syndromic Multiplex Diagnostic Business (2016-2021) & (US$ Million)
Table 96. Bio-Rad Laboratories Recent Development
Table 97. Luminex Company Details
Table 98. Luminex Business Overview
Table 99. Luminex Revenue in Syndromic Multiplex Diagnostic Business (2016-2021) & (US$ Million)
Table 100. Luminex Recent Development
Table 101. bioMérieux Company Details
Table 102. bioMérieux Business Overview
Table 103. bioMérieux Syndromic Multiplex Diagnostic Product
Table 104. bioMérieux Revenue in Syndromic Multiplex Diagnostic Business (2016-2021) & (US$ Million)
Table 105. bioMérieux Recent Development
Table 106. Qiagen Company Details
Table 107. Qiagen Business Overview
Table 108. Qiagen Syndromic Multiplex Diagnostic Product
Table 109. Qiagen Revenue in Syndromic Multiplex Diagnostic Business (2016-2021) & (US$ Million)
Table 110. Qiagen Recent Development
Table 111. Alveo Technologies Company Details
Table 112. Alveo Technologies Business Overview
Table 113. Alveo Technologies Syndromic Multiplex Diagnostic Product
Table 114. Alveo Technologies Revenue in Syndromic Multiplex Diagnostic Business (2016-2021) & (US$ Million)
Table 115. Alveo Technologies Recent Development
Table 116. Mesa Biotech Company Details
Table 117. Mesa Biotech Business Overview
Table 118. Mesa Biotech Syndromic Multiplex Diagnostic Product
Table 119. Mesa Biotech Revenue in Syndromic Multiplex Diagnostic Business (2016-2021) & (US$ Million)
Table 120. Mesa Biotech Recent Development
Table 121. Applied BioCode Company Details
Table 122. Applied BioCode Business Overview
Table 123. Applied BioCode Syndromic Multiplex Diagnostic Product
Table 124. Applied BioCode Revenue in Syndromic Multiplex Diagnostic Business (2016-2021) & (US$ Million)
Table 125. Applied BioCode Recent Development
Table 126. Akonni Biosystems Company Details
Table 127. Akonni Biosystems Business Overview
Table 128. Akonni Biosystems Syndromic Multiplex Diagnostic Product
Table 129. Akonni Biosystems Revenue in Syndromic Multiplex Diagnostic Business (2016-2021) & (US$ Million)
Table 130. Akonni Biosystems Recent Development
Table 131. Diagenode Diagnostics Company Details
Table 132. Diagenode Diagnostics Business Overview
Table 133. Diagenode Diagnostics Syndromic Multiplex Diagnostic Product
Table 134. Diagenode Diagnostics Revenue in Syndromic Multiplex Diagnostic Business (2016-2021) & (US$ Million)
Table 135. Diagenode Diagnostics Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Syndromic Multiplex Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Gastrointestinal Syndromic Multiplex Diagnostic Features
Figure 3. Central Nervous System Syndromic Multiplex Diagnostic Features
Figure 4. Others Features
Figure 5. Global Syndromic Multiplex Diagnostic Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Diagnostics Laboratories Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. Syndromic Multiplex Diagnostic Report Years Considered
Figure 11. Global Syndromic Multiplex Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Syndromic Multiplex Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Syndromic Multiplex Diagnostic Market Share by Regions: 2020 VS 2027
Figure 14. Global Syndromic Multiplex Diagnostic Market Share by Regions (2022-2027)
Figure 15. Global Syndromic Multiplex Diagnostic Market Share by Players in 2020
Figure 16. Global Top Syndromic Multiplex Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Syndromic Multiplex Diagnostic as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Syndromic Multiplex Diagnostic Revenue in 2020
Figure 18. Global Syndromic Multiplex Diagnostic Revenue Market Share by Type (2016-2021)
Figure 19. Global Syndromic Multiplex Diagnostic Revenue Market Share by Type (2022-2027)
Figure 20. North America Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Syndromic Multiplex Diagnostic Market Share by Type (2016-2027)
Figure 22. North America Syndromic Multiplex Diagnostic Market Share by Application (2016-2027)
Figure 23. North America Syndromic Multiplex Diagnostic Market Share by Country (2016-2027)
Figure 24. United States Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Syndromic Multiplex Diagnostic Market Share by Type (2016-2027)
Figure 28. Europe Syndromic Multiplex Diagnostic Market Share by Application (2016-2027)
Figure 29. Europe Syndromic Multiplex Diagnostic Market Share by Country (2016-2027)
Figure 30. Germany Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Syndromic Multiplex Diagnostic Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Syndromic Multiplex Diagnostic Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Syndromic Multiplex Diagnostic Market Share by Region (2016-2027)
Figure 40. China Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Syndromic Multiplex Diagnostic Market Share by Type (2016-2027)
Figure 48. Latin America Syndromic Multiplex Diagnostic Market Share by Application (2016-2027)
Figure 49. Latin America Syndromic Multiplex Diagnostic Market Share by Country (2016-2027)
Figure 50. Mexico Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Syndromic Multiplex Diagnostic Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Syndromic Multiplex Diagnostic Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Syndromic Multiplex Diagnostic Market Share by Country (2016-2027)
Figure 56. Turkey Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Syndromic Multiplex Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2016-2021)
Figure 60. Hologic Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2016-2021)
Figure 61. Bosch Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2016-2021)
Figure 62. Danaher Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2016-2021)
Figure 64. Danaher Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2016-2021)
Figure 65. Bio-Rad Laboratories Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2016-2021)
Figure 66. Luminex Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2016-2021)
Figure 67. bioMérieux Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2016-2021)
Figure 68. Qiagen Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2016-2021)
Figure 69. Alveo Technologies Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2016-2021)
Figure 70. Mesa Biotech Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2016-2021)
Figure 71. Applied BioCode Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2016-2021)
Figure 72. Akonni Biosystems Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2016-2021)
Figure 73. Diagenode Diagnostics Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Global Protein-based Multiplex Assays Market Size, Status and Forecast 2021-2027
QFJ1-5972 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、タンパク質ベースマルチプレックスアッセイの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（試薬・消耗品、機器・付属品、ソフトウェア・サービス）、用途別市場規模（コンパニオン診断、研究開発、臨床診断）、主...

世界の核酸ベースマルチプレックスアッセイ市場規模・現状・予測（2021年-2027年）

Global Nucleic Acid-Based Multiplex Assays Market Size, Status and Forecast 2021-2027
QFJ1-5901 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、核酸ベースマルチプレックスアッセイの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（試薬＆消耗品、機器＆付属品、ソフトウェア＆サービス）、用途別市場規模（コンパニオン診断、研究開発、臨床診断）、主要地域...

世界のB型肝炎診断検査市場規模・現状・予測（2021年-2027年）

Global Hepatitis B Diagnostic Tests Market Size, Status and Forecast 2021-2027
QFJ1-4302 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、B型肝炎診断検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素免疫測定キット、ポイントオブケア検査キット）、用途別市場規模（病院、診療所、診断センター、ホームケア）、主要地域別市場規模（北米、ア...

世界の関節リウマチ診断装置市場規模・現状・予測（2021年-2027年）

Global Rheumatoid Arthritis Diagnostic Device Market Size, Status and Forecast 2021-2027
QFJ1-5335 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、関節リウマチ診断装置の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（分析装置、消耗品）、用途別市場規模（病院、研究所、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の子癇前症診断市場規模・現状・予測（2021年-2027年）

Global Preeclampsia Diagnostic Market Size, Status and Forecast 2021-2027
QFJ1-5315 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、子癇前症診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液検査、尿検査）、用途別市場規模（病院、専門クリニック、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界のSTD診断検査市場規模・現状・予測（2021年-2027年）

Global Diagnostic Testing For STDs Market Size, Status and Forecast 2021-2027
QFJ1-4128 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、STD診断検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（梅毒検査、淋病検査、クラミジア検査、単純ヘルペスウイルス検査、ヒト免疫不全ウイルス検査、ヒトパピローマウイルス検査、その他）、用途別市場規...

世界のAIベース医療診断ツール市場規模・現状・予測（2021年-2027年）

Global AI-based Medical Diagnostic Tools Market Size, Status and Forecast 2021-2027
QFJ1-5069 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、AIベース医療診断ツールの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医用画像ツール、自動検出システム、その他）、用途別市場規模（アイケア、腫瘍、放射線、心臓血管、病理、その他（整形外科、希少疾患）...

世界の肝炎ウイルス診断検査市場規模・現状・予測（2021年-2027年）

Global Hepatitis Viruses Diagnostic Tests Market Size, Status and Forecast 2021-2027
QFJ1-4304 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、肝炎ウイルス診断検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素免疫測定法（EIA）、組換免疫ブロット法（RIBA）、転写媒介増幅法（TMA）、ポリメラーゼ連鎖反応法（PCR）、その他）、用途...

世界の救命救急診断（CCD）市場規模・現状・予測（2021年-2027年）

Global Critical Care Diagnostic (CCD) Market Size, Status and Forecast 2021-2027
QFJ1-4068 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、救命救急診断（CCD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ルーチン＆特殊化学、フローサイトメトリー、血液学、免疫タンパク質、微生物＆感染症、凝固検査）、用途別市場規模（救急治療室、手術室、...

世界の呼吸器感染症診断市場規模・現状・予測（2021年-2027年）

Global Respiratory Infection Diagnostic Market Size, Status and Forecast 2021-2027
QFJ1-5333 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、呼吸器感染症診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（微生物、PCR、NGS、イムノアッセイ）、用途別市場規模（病院研究室、外来研究室）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のタンパク質ベースマルチプレックスアッセイ市場規模・現状・予測（2021年-2027年） Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect …
世界の核酸ベースマルチプレックスアッセイ市場規模・現状・予測（2021年-2027年） Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect …
世界の肝炎ウイルス診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hepatitis Viruses Diagnostic Tests Market The global Hepatitis Viruses Diagnostic Tests market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …
世界の子癇前症診断市場規模・現状・予測（2021年-2027年） Preeclampsia, a rapidly progressive disorder is characterized by elevated blood pressure and excessive protein in the urine of pregnant women. Market Analysis and Insights: Global Preeclampsia Diagnostic Market The global Preeclampsia Diagnostic market size is projected to reach US$ XX million by 20…
世界の呼吸器感染症診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Respiratory Infection Diagnostic Market The global Respiratory Infection Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…